Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 655

1.

Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS).

Lee J, Ryu H, Yoon YJ, Kowall NW, Ryu H.

Curr Med Chem. 2014 Jul 6. [Epub ahead of print]

PMID:
25005187
[PubMed - as supplied by publisher]
2.

Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity.

Olmos G, Lladó J.

Mediators Inflamm. 2014;2014:861231. doi: 10.1155/2014/861231. Epub 2014 May 21. Review.

PMID:
24966471
[PubMed - in process]
Free PMC Article
3.

Activity of D-amino acid oxidase is widespread in the human central nervous system.

Sasabe J, Suzuki M, Imanishi N, Aiso S.

Front Synaptic Neurosci. 2014 Jun 10;6:14. doi: 10.3389/fnsyn.2014.00014. eCollection 2014.

PMID:
24959138
[PubMed]
Free PMC Article
4.

Stem cell factor-activated bone marrow ameliorates amyotrophic lateral sclerosis by promoting protective microglial migration.

Terashima T, Kojima H, Urabe H, Yamakawa I, Ogawa N, Kawai H, Chan L, Maegawa H.

J Neurosci Res. 2014 Jul;92(7):856-69.

PMID:
24936617
[PubMed - in process]
Free PMC Article
5.

Biomarkers And Future Targets For Development In Amyotrophic Lateral Sclerosis.

Menon P, Kiernan MC, Vucic S.

Curr Med Chem. 2014 Jun 1. [Epub ahead of print]

PMID:
24934359
[PubMed - as supplied by publisher]
6.

Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis.

Yacila G, Sari Y.

Curr Med Chem. 2014 Jun 1. [Epub ahead of print]

PMID:
24934355
[PubMed - as supplied by publisher]
7.

Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.

Vucic S, Rothstein JD, Kiernan MC.

Trends Neurosci. 2014 Jun 10. pii: S0166-2236(14)00085-X. doi: 10.1016/j.tins.2014.05.006. [Epub ahead of print] Review.

PMID:
24927875
[PubMed - as supplied by publisher]
8.

Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.

Yin HZ, Yu S, Hsu CI, Liu J, Acab A, Wu R, Tao A, Chiang BJ, Weiss JH.

Exp Neurol. 2014 Jun 8. pii: S0014-4886(14)00190-3. doi: 10.1016/j.expneurol.2014.06.003. [Epub ahead of print]

PMID:
24918341
[PubMed - as supplied by publisher]
9.

Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis.

Cecchi M, Messina P, Airoldi L, Pupillo E, Bandettini di Poggio M, Calvo A, Filosto M, Lunetta C, Mandrioli J, Pisa F, Pastorelli R, Beghi E; Eurals Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun 6:1-5. [Epub ahead of print]

PMID:
24904978
[PubMed - as supplied by publisher]
10.

Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.

Dumont AO, Goursaud S, Desmet N, Hermans E.

PLoS One. 2014 May 16;9(5):e97649. doi: 10.1371/journal.pone.0097649. eCollection 2014.

PMID:
24836816
[PubMed - in process]
Free PMC Article
11.

The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS).

Paul P, de Belleroche J.

Front Synaptic Neurosci. 2014 Apr 16;6:10. doi: 10.3389/fnsyn.2014.00010. eCollection 2014. Review.

PMID:
24795623
[PubMed]
Free PMC Article
12.

[What are the applications of biomarkers in ALS today?].

Blasco H, Corcia P, Pradat PF.

Presse Med. 2014 May;43(5):569-79. doi: 10.1016/j.lpm.2013.12.014. Epub 2014 Apr 29. Review. French.

PMID:
24785140
[PubMed - indexed for MEDLINE]
13.

Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.

Foran E, Rosenblum L, Bogush A, Pasinelli P, Trotti D.

Glia. 2014 Aug;62(8):1241-53. doi: 10.1002/glia.22677. Epub 2014 Apr 21.

PMID:
24753081
[PubMed - in process]
14.

The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43.

Tran LT, Gentil BJ, Sullivan KE, Durham HD.

J Neurochem. 2014 Apr 9. doi: 10.1111/jnc.12738. [Epub ahead of print]

PMID:
24716897
[PubMed - as supplied by publisher]
15.

EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population.

Nishioka K, Funayama M, Vilariño-Güell C, Ogaki K, Li Y, Sasaki R, Kokubo Y, Kuzuhara S, Kachergus JM, Cobb SA, Takahashi H, Mizuno Y, Farrer MJ, Ross OA, Hattori N.

Parkinsonism Relat Disord. 2014 Jun;20(6):659-61. doi: 10.1016/j.parkreldis.2014.03.004. Epub 2014 Mar 18.

PMID:
24704100
[PubMed - in process]
16.

Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.

Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, Comi GP, Corti S.

Cell Mol Life Sci. 2014 Apr 4. [Epub ahead of print]

PMID:
24699704
[PubMed - as supplied by publisher]
17.

Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma.

Wang AL, Carroll RC, Nawy S.

PLoS One. 2014 Mar 7;9(3):e91288. doi: 10.1371/journal.pone.0091288. eCollection 2014.

PMID:
24608178
[PubMed - in process]
Free PMC Article
18.

Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.

Kong Q, Chang LC, Takahashi K, Liu Q, Schulte DA, Lai L, Ibabao B, Lin Y, Stouffer N, Das Mukhopadhyay C, Xing X, Seyb KI, Cuny GD, Glicksman MA, Lin CL.

J Clin Invest. 2014 Mar 3;124(3):1255-67. doi: 10.1172/JCI66163. Epub 2014 Feb 24.

PMID:
24569372
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

Limpert AS, Cosford ND.

J Clin Invest. 2014 Mar 3;124(3):964-7. doi: 10.1172/JCI74608. Epub 2014 Feb 24.

PMID:
24569369
[PubMed - indexed for MEDLINE]
20.

The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction.

Machamer JB, Collins SE, Lloyd TE.

Hum Mol Genet. 2014 Jul 15;23(14):3810-22. doi: 10.1093/hmg/ddu094. Epub 2014 Feb 25.

PMID:
24569165
[PubMed - in process]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk